EICHORCondition: Healthy · Sponsor: University Hospital, Clermont-Ferrand
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Acetaminophen is one of the most widely used analgesic in the world, recommended for the symptomatic treatment of fever and pain. The purpose of this study is to assess the effectiveness of acetaminophen in association with N-acetylcysteine. The objective of this study is to evaluate if the association in healthy volunteers of acetaminophen and N-acétylcystéine 1. \- decrease the antinociceptive effect of acetaminophen in comparison to a group control 2. \- and if this antinociceptive effect may depend of the genetic polymorphism of GSH enzyme.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Male * Between 18 and 45 years old * Without treatment during the 7 days before inclusion specially no use of antalgic and anti-inflammatory * Cooperation and understanding enough to conform to the study obligations -Having given free, informed written consent * Affiliated at system of French social security * Inscription or acceptation of inscription in the national register of volunteers involved in trials. Exclusion Criteria: * Patient with one or many contraindication for the administration of the trial's products, * Patient that have taken N-acetylcysteine as bronchial thinner during the last 3 days, * Patient with medical or surgical history judged by the investigator or his representative as being not compatible with the clinical trial * Patient with disease progression during inclusion, * Patient with excessive consumption of alcohol, tobacco (+ than 10 cigarette/day), coffee, tea or drinks with caffeine (equivalent to more than 4 cup a day) or any addiction to drugs, * Patient with a heat pain mean threshold during training higher or equal to 46.5°C, * Patient who participated in another clinical trial, located in exclusion period or received benefits \> 4500 euros during 12 months before the beginning of trial, * Patient with cooperation and understanding that do not allow him to follow the trial, * Patients with minor or under guardianship, * No affiliation at system of French social security
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| CHU de Clermont-Ferrand | Clermont-Ferrand, France | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02206178